MYCN

Mingpeng Xu1, Hanhan Shi2,3, Yongning Shen2,3

  • 1Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.

Ophthalmology science
|June 18, 2025
PubMed
概括

腔腔视网膜母细胞瘤 (CRB),一个独特的RB亚型,由于MYCN表达率较低,显示出良好的预后. 这一发现将减少的MYCN与半透明腔和更好的患者结果联系在一起.